GATA6 and neoplasm: Immunohistochemical staining revealed a significant reduction in Ki67-positive cells in tumors derived from GATA6- or TET1-depleted CAFs (P < 0.01 vs. control; Fig. 6B), indicating suppressed tumor cell proliferation.